✦ LIBER ✦

Pharmacokinetics and Safety of Ebastine in Patients with Impaired Hepatic Function Compared with Healthy Volunteers

✍ Scribed by Dr Kenneth C. Lasseter, Stacy C. Dilzer, Ramon Vargas, Scott Waldman, Robert J. Noveck

Book ID: 119926550
Publisher: Springer International Publishing AG
Year: 2004
Tongue: English
Weight: 128 KB
Volume: 43
Category: Article
ISSN: 0312-5963
DOI: 10.2165/00003088-200443020-00004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and Safety of Ebastine

Pharmacokinetics and Safety of Ebastine in Healthy Subjects and Patients with Renal Impairment

✍ Dr Robert J. Noveck, Richard A. Preston, Suzanne K. Swan 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 140 KB

Pharmacokinetics of ciprofloxacin in hea

Pharmacokinetics of ciprofloxacin in healthy volunteers and patients with impaired kidney function

✍ Webb, D. B. ;Roberts, D. E. ;Williams, J. D. ;Asscher, A. W. 📂 Article 📅 1986 🏛 Oxford University Press 🌐 English ⚖ 198 KB

Comparative enantioselective pharmacokin

Comparative enantioselective pharmacokinetic studies of celiprolol in healthy volunteers and patients with impaired renal function

✍ C. Hartmann; M. Frölich; D. Krauß; H. Spahn-Langguth; H. Knauf; E. Mutschler 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 359 KB

The pharmacokinetics of the beta 1-selective adrenergic antagonist (R,S)-celiprolol has been studied after oral administration of 200 mg celiprolol-HCl to 8 healthy volunteers and 8 patients with various degrees of impaired renal function. No significant difference was found between the two enantiom

Pharmacokinetics and Safety of Intraveno

Pharmacokinetics and Safety of Intravenous and Oral Telmisartan 20 mg and 120 mg in Subjects with Hepatic Impairment Compared with Healthy Volunteers

✍ Stangier, Joachim (author);Su, Chung‐An P. F. (author);Schöndorfer, G. (author); 📂 Article 📅 2000 🏛 Wiley 🌐 English ⚖ 156 KB

Comparative pharmacokinetics and cardiov

Comparative pharmacokinetics and cardiovascular effects of tiapamil in healthy volunteers and patients with hepatic cirrhosis

✍ P. H. Hinderling; M. Eckert; S. Gasic; H. G. Eichler; R. Pötzi; P. Heizmann 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 930 KB

The pharmacokinetics of lamivudine in pa

The pharmacokinetics of lamivudine in patients with impaired hepatic function

✍ M. A. Johnson; J. Horak; P. Breuel 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 266 KB